Disclosure Of First-Time Adoption [Text Block]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	—	—	105 001 BGN	—	—	—	—	8 431 BGN	101 585 BGN	—	—	4 369 BGN	—	—	—	- BGN	7 701 BGN	84 500 BGN	105 001 BGN	—	—	8 147 BGN	4 587 BGN	101 585 BGN	4 351 BGN	101 585 BGN	- BGN	84 500 BGN	- BGN	1 937 BGN	98 819 BGN	84 500 BGN	4 375 BGN	98 819 BGN	8 007 BGN
Comprehensive income	- BGN	3 416 BGN	18,000 BGN	—	3 416 BGN	- BGN	3 398 BGN	- BGN	—	—	- BGN	2 766 BGN	—	2 790 BGN	- BGN	- BGN	—	—	—	—	24,000 BGN	2 766 BGN	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit (loss)	- BGN	3 398 BGN	- BGN	—	3 398 BGN	- BGN	3 398 BGN	- BGN	—	—	- BGN	2 790 BGN	—	2 790 BGN	- BGN	- BGN	—	—	—	—	- BGN	2 790 BGN	—	—	—	—	—	—	—	—	—	—	—	—	—	—